Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
株式のランク
#2197
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
株価
$3.40
時価総額
$9.07B
変化（1日）
-1.61%
変化（1年）
-16.08%
国
CN
取引 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
カテゴリー
Healthcare
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.（600196）の利益
2026 時点の利益 TTM: 0
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. の利益の推移（2001 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2025 | $730.66M | 27.92% |
| 2024 | $571.20M | 23.86% |
| 2023 | $461.19M | -30.46% |
| 2022 | $663.16M | -30.25% |
| 2021 | $950.72M | 32.77% |
| 2020 | $716.07M | 10.17% |
| 2019 | $649.94M | 24.89% |
| 2018 | $520.40M | -16.64% |
| 2017 | $624.28M | 21.36% |
| 2016 | $514.42M | -0.93% |
| 2015 | $519.24M | 18.33% |
| 2014 | $438.82M | 15.05% |
| 2013 | $381.42M | 12.03% |
| 2012 | $340.46M | 24.30% |
| 2011 | $273.89M | 50.41% |
| 2010 | $182.10M | -61.92% |
| 2009 | $478.18M | 290.45% |
| 2008 | $122.47M | 18.23% |
| 2007 | $103.59M | 135.84% |
| 2006 | $43.92M | 31.65% |
| 2005 | $33.36M | 92.26% |
| 2004 | $17.35M | -58.15% |
| 2003 | $41.46M | 96.02% |
| 2002 | $21.15M | 8.96% |
| 2001 | $19.41M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
